Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Israel-Gaza conflict.
Silverberg MS, Rubin DT, Steinhart AH, Cohen LB, Rotter JI. Silverberg MS, et al. Among authors: rubin dt. Lancet. 2009 Mar 14;373(9667):891-2. doi: 10.1016/S0140-6736(09)60538-9. Lancet. 2009. PMID: 19286075 No abstract available.
Frequency of Spondyloarthritis Symptoms Among U.S. Patients with Inflammatory Bowel Disease: A Cross-sectional Multi-Center Study.
Ermann J, Hong SJ, Stahly A, Dalal RS, Malik F, Scott FI, Click B, Way A, Davis JM 3rd, Shmais M, Raffals LE, Jan R, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland JE, Patel S, Kuhn KA, Michael HW. Ermann J, et al. Among authors: rubin dt. Arthritis Care Res (Hoboken). 2025 Jan 2. doi: 10.1002/acr.25493. Online ahead of print. Arthritis Care Res (Hoboken). 2025. PMID: 39748206
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S. Vermeire S, et al. Among authors: rubin dt. Lancet Gastroenterol Hepatol. 2024 Dec 2:S2468-1253(24)00272-3. doi: 10.1016/S2468-1253(24)00272-3. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 39637881 Free article.
508 results